ADHD Psychiatrist in Dubai
Looking for an ADHD psychiatrist in Dubai? A licensed psychiatrist confirms the diagnosis, checks your health and prescribes the ADHD medication that UAE rules allow.
Your first visit covers your symptoms, your history and your treatment options, whether you are new to ADHD or already on medication.
- Licensed psychiatrists
- Prescriptions in line with UAE rules
- Open every day, 07:00 – 23:00
In short
- An ADHD psychiatrist diagnoses ADHD, checks for other conditions and prescribes medication. In the UAE, controlled ADHD medicines are prescribed by licensed doctors where UAE rules allow.
- Adults need at least 5 symptoms of inattention or 5 of hyperactivity and impulsivity, present often, for 6 months or more, in more than one setting.
- The combination of CBT and medication is the preferred treatment.
- Stimulants reduced symptoms more than non-stimulants in a meta-analysis of 11 trials with 1,991 adults (Cohen's d 0.67 against 0.59).
- Check-ups take place about once a month until the dose is stable.
- Children are assessed too: see the child ADHD assessment page.
What does an ADHD psychiatrist do?
An ADHD psychiatrist confirms the diagnosis, looks for other conditions that mimic or accompany ADHD, prescribes medication where it fits and follows the treatment over time. A licensed psychiatrist prescribes controlled ADHD medicines only where UAE rules allow.
At your appointment the psychiatrist tells you which ADHD medication you can be prescribed and which other steps help, such as CBT.
No diagnosis yet? Start with an ADHD assessment in Dubai.
Bring:
- Your current prescription or pharmacy record
- Your earlier ADHD diagnosis or report, if you have one
- A list of all other medicines you take
- Your passport or Emirates ID
How ADHD is diagnosed and treated: what the research shows
The sections below follow the order of a typical treatment path: diagnosis, first treatment, therapy and follow-up.
How is ADHD diagnosed in adults?
The DSM-5-TR criteria require at least 5 symptoms of inattention or at least 5 of hyperactivity and impulsivity in adolescents from 17 years and in adults. The symptoms occur often, persist for at least 6 months, appear in more than one setting, began before age 12 and impair work, study or social life. Other physical or mental health conditions that could explain the symptoms need to be excluded. A good or poor response to a stimulant cannot confirm or refute the diagnosis.
Which treatment comes first?
The combination of CBT and medication is preferred, and stimulants are the first-line medicines. A meta-analysis of 11 trials with 1,991 adults (Mészáros 2009) found a Cohen’s d of 0.67 for stimulants and 0.59 for non-stimulants. A network meta-analysis of 51 trials with 8,131 adults (Cortese, Lancet Psychiatry 2018) found amphetamines slightly ahead of methylphenidate after about 12 weeks (SMD -0.29).
Does therapy add something to medication?
In a trial with 88 adults, 12 group CBT sessions with or without a stimulant gave better results at the end of treatment and at 3 months, and the results were similar at 6 months (Cherkasova, J Atten Disord 2020).
What does treatment change over time?
Among 2,319,450 patients in a US insurance database, the collision risk was 38 percent lower in men (OR 0.62) and 42 percent lower in women (OR 0.58) in the months on ADHD medication (Chang, JAMA Psychiatry 2017). In a Swedish registry study of about 149,000 people, medication was linked to lower all-cause mortality (HR 0.79) (Li, JAMA 2024). In a cohort of 148,581 people with ADHD (Zhang, BMJ 2025), medication was linked to lower risks of suicidal behaviour (RR 0.83), substance misuse (RR 0.85) and criminal convictions (RR 0.87).
How does follow-up work?
Treatment starts at a low dose, and the dose rises about weekly. Check-ups take place about once a month until the dose is stable, with blood pressure and pulse at each visit. An ECG is added with heart disease or heart symptoms.
Medicine pages: Adderall prescription in Dubai, Vyvanse prescription in Dubai and Ritalin and Concerta prescription in Dubai.
Seeing an ADHD psychiatrist in Dubai
Some ADHD medicines are controlled in the UAE. Amphetamine, dexamfetamine, lisdexamfetamine and methylphenidate are on the Emirates Drug Establishment list (Psychotropic Schedule II), so only a licensed doctor prescribes them, where UAE rules allow.
Travelling with medication: Taking ADHD medication to Dubai. Assessment for a child or teen: Child ADHD assessment in Dubai.
Frequently asked questions about ADHD psychiatrists in Dubai
Short answers about diagnosis, treatment and what to expect at the first visit.
The psychiatrist confirms the diagnosis, checks for other conditions, prescribes medication where it fits and follows treatment over time.
Controlled ADHD medicines are prescribed by licensed doctors, and only where UAE rules allow. Amphetamine and methylphenidate are in Psychotropic Schedule II of the Emirates Drug Establishment list.
Adults need at least 5 symptoms of inattention or 5 of hyperactivity and impulsivity. The symptoms occur often, last at least 6 months, appear in more than one setting, began before age 12 and impair daily life.
The combination of CBT and medication is preferred, and stimulants are the first-line medicines. In a meta-analysis of 1,991 adults, stimulants reached a Cohen’s d of 0.67 and non-stimulants 0.59.
About once a month until the dose is stable, with blood pressure and pulse at each visit, and less often afterwards.
Yes, children and teens are assessed too. See Child ADHD assessment in Dubai.
Start with an ADHD assessment in Dubai. A prescription follows a confirmed diagnosis.
More ADHD guides
Book your appointment
Two fields are enough, because a short call settles more than a long form. Prefer to write? WhatsApp reaches the clinic phone directly.
Request an appointment
We reply within clinic hours. Your details are used only to answer your enquiry.
Sources
- Emirates Drug Establishment, controlled and semi-controlled medicines list
- Cortese S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018.
- Mészáros A, et al. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 2009.
- Cherkasova MV, et al. Efficacy of cognitive behavioral therapy with and without medication for adults with ADHD: a randomized clinical trial. J Atten Disord 2020.
- Chang Z, et al. Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 2017.
- Li L, et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA 2024.
- Zhang L, et al. ADHD medication and risk of suicidal behaviour, substance misuse and criminality. BMJ 2025.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.